National Comprehensive Cancer Network

About NCCN

NCCN Flash Update: NCCN Guidelines & NCCN Compendium Updated for Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma

NCCN has published updates to the NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines®) and the NCCN Drugs & Biologics Compendium (NCCN Compendium®) for Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma. These NCCN Guidelines® are currently available as Version 2.2018.

  • The NCCN Categories of Preference has been applied to the suggested treatment regimens. (CSLL-D)
    • The regimens are listed under two groups: "preferred regimens" and "other recommended regimens".
    • "In order of preference" was removed from all suggested treatment pages.

*For your reference, the previous update (Version 1.2018) to the NCCN Guidelines for Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma, published on August 21, 2017, is available at the following link: https://www.nccn.org/professionals/physician_gls/pdf/cll.pdf

 

For the complete updated versions of the NCCN Guidelines, NCCN Guidelines with NCCN Evidence Blocks™, the NCCN Compendium®, the NCCN Biomarkers Compendium®, the NCCN Chemotherapy Order Templates (NCCN Templates®), the NCCN Radiation Therapy Compendium™, and the NCCN Imaging Appropriate Use Criteria (NCCN Imaging AUC™), please visit NCCN.org.

To view the NCCN Guidelines for Patients®, please visit NCCN.org/patients.

Free NCCN Guidelines apps for iPhone, iPad, and Android smartphones & tablets are now available! Visit NCCN.org/apps

About NCCN Flash Updates™ 
NCCN Flash Updates™ is a subscription service from NCCN that provides timely notification of updated and new information appearing in the NCCN Guidelines, the NCCN Compendium®, and other NCCN Content. 

Subscribe to NCCN Flash Updates™ 

National Comprehensive Cancer Network® (NCCN®)
275 Commerce Drive, Suite 300
Fort Washington, PA 19034
Telephone: +1 215.690.0300 Fax: +1 215.690.0280 

Access information on permissions and licensing of NCCN Content  

© 2017 National Comprehensive Cancer Network. All Rights Reserved.